Steve Kolb is a physician-scientist at the Ohio State University Wexner Medical Center. He is Associate Professor in the Department of Neurology and Department of Biological Chemistry & Pharmacology whose laboratory is focused upon motor neuron biology and disease pathogenesis. Dr. Kolb obtained a BA in Biochemistry at the University of Texas at Austin. He earned his MD and PhD degrees at the University of Texas Health Science Center in Houston, where he completed graduate studies in Neuroscience in the laboratory of Dr. Neal Waxham. It was during neurology residency at the University of Pennsylvania that he got to know a person with ALS for the first time. Since then, he has been committed to understand the molecular basis of motor neuron disease pathogenesis and to develop effective therapies. He began his involvement in spinal muscular atrophy (SMA) research as a postdoctoral fellow in the laboratory of Dr. Gideon Dreyfuss at Penn and continues to be involved in SMA research on basic, translational and clinical levels of inquiry in a fertile and collaborative environment at Ohio State. Most recently, he led the premier clinical study of the NINDS-sponsored NeuroNEXT Clinical Trial Network that has provided important natural history data for clinical trials in infants with SMA. Now, as Director of the OSU ALS/MND Clinic and Translational Research Program, Dr. Kolb is very excited to offer people with ALS the opportunity to be a part of the AnswerALS Team that will contribute to the development of a new era of effective ALS therapies